We are very happy to announce the creation of a new M2 program within the Master Cancer (Research Center for Cancer (CRCL), University of Lyon (France)): “Cancer Bioengineering”.
Thanks to a transdisciplinary approach and industrial partnerships, this new M2 program aims to give students from biological/medical background
the practical and theoretical tools to understand and reproduce the physico-chemical complexity of cancers.
It wil form future bioengineers and researchers, capable of proposing innovative solutions for cancer models of scientific and therapeutic utility.
For more information : https://clarolineconnect.univ-lyon1.fr/icap_website/545/75779
New applications are now open until May 24th, 2022 on https://ecandidat.univ-lyon1.fr/#!accueilView
Lectures will start in hybrid mode in october 2020, with practical starting beginning of november.
Do not hesitate to contact us if you have any questions about the Program
Please, spread this message among your students and colleagues.
with our best regards,
Olivier Meurette, Associate Professor, CRLC
Charlotte Rivière, Associate Professor, ILM and µFab platform, CRCL
To apply for this job email your details to firstname.lastname@example.org